SCHEMBL32688361

SCHEMBL32688361

CN(C(=O)c1cccc(-c2cc(=O)[nH]c(SCc3nnn[nH]3)c2C#N)c1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ HPGD P15428 3/20 0.41
▸ GAA P10253 1/20 0.38
▸ ACMSD Q8TDX5 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ IKBKB O14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688135 0.88 ACMSD (0.37) ALDH1A1KMT2AHPGDGAAACMSD
SCHEMBL32688247 0.87 ACMSD (0.44) ALDH1A1KMT2AHPGDACMSDADORA3
SCHEMBL32688125 0.87 ACMSD (0.37) ALDH1A1KMT2AHPGDGAAACMSD
SCHEMBL32688271 0.84 ALDH1A1 (0.42) ALDH1A1KMT2AHPGDACMSDMEN1
SCHEMBL32687986 0.83 KMT2A (0.39) ALDH1A1KMT2AHPGDGAAACMSD
SCHEMBL32688485 0.83 KMT2A (0.33) ALDH1A1KMT2AHPGDGAAACMSD
SCHEMBL32688038 0.83 ACMSD (0.45) ALDH1A1KMT2AHPGDACMSDMEN1
SCHEMBL32688183 0.83 KISS1R (0.45) ALDH1A1KMT2AHPGDADORA1IKBKB
SCHEMBL32688221 0.81 SIRT2 (0.46) KMT2AGAAMEN1POLBHTT
SCHEMBL32688138 0.80 KMT2A (0.41) ALDH1A1KMT2AHPGDACMSDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885KMT2A 3400/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback